Royal Philips/$PHG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Royal Philips
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Ticker
$PHG
Sector
Primary listing
NYSE
Employees
67,263
Headquarters
Website
Royal Philips Metrics
BasicAdvanced
$27B
135.69
$0.21
0.79
$0.82
2.94%
Price and volume
Market cap
$27B
Beta
0.79
52-week high
$31.83
52-week low
$20.77
Average daily volume
714K
Dividend rate
$0.82
Financial strength
Current ratio
1.259
Quick ratio
0.715
Long term debt to equity
69.005
Total debt to equity
80.957
Dividend payout ratio (TTM)
182.10%
Interest coverage (TTM)
3.58%
Profitability
EBITDA (TTM)
1,907.219
Gross margin (TTM)
43.84%
Net profit margin (TTM)
0.91%
Operating margin (TTM)
5.92%
Effective tax rate (TTM)
79.10%
Revenue per employee (TTM)
$318,450
Management effectiveness
Return on assets (TTM)
2.37%
Return on equity (TTM)
1.50%
Valuation
Price to earnings (TTM)
135.686
Price to revenue (TTM)
1.231
Price to book
2.17
Price to tangible book (TTM)
-13.29
Price to free cash flow (TTM)
50.648
Free cash flow yield (TTM)
1.97%
Free cash flow per share (TTM)
0.551
Dividend yield (TTM)
2.94%
Forward dividend yield
2.94%
Growth
Revenue change (TTM)
-1.53%
Earnings per share change (TTM)
-139.37%
3-year revenue growth (CAGR)
1.27%
10-year revenue growth (CAGR)
-2.52%
3-year earnings per share growth (CAGR)
-61.88%
10-year earnings per share growth (CAGR)
-8.07%
3-year dividend per share growth (CAGR)
1.75%
10-year dividend per share growth (CAGR)
1.34%
What the Analysts think about Royal Philips
Analyst ratings (Buy, Hold, Sell) for Royal Philips stock.
Bulls say / Bears say
After the U.S.-EU trade deal and mitigation efforts, Philips raised its full-year adjusted EBITA margin guidance to 11.3%–11.8%, up 50 bps from its previous outlook, reflecting improved profitability (Reuters).
In Q2 2025, Philips achieved a 12.4% adjusted EBITA margin, surpassing analysts’ 9.9% forecast, driven by cost efficiencies and pricing actions (Reuters).
Philips’ comparable order intake grew 6% in Q2 2025, propelled by AI-powered diagnostic innovations, indicating strong demand momentum across its Diagnosis & Treatment segment (Reuters).
Philips cut its 2025 adjusted EBITA margin forecast to 10.8%–11.3%, down from 11.8%–12.3%, citing a €250 million–€300 million hit from U.S.-China tariffs, signaling sustained margin pressure from trade tensions (Reuters).
Despite the U.S.-EU agreement, Philips still anticipates €150 million–€200 million in tariff-related costs for 2025 and cautions that tariffs remain dynamic, underscoring ongoing trade volatility risk (Reuters).
Philips forecasts a mid- to high-single-digit decline in China sales for 2025, with double-digit drops in Q4 2024, which could constrain growth across its core segments (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.
Royal Philips Financial Performance
Revenues and expenses
Royal Philips Earnings Performance
Company profitability
Royal Philips News
AllArticlesVideos
Philips, Philips Foundation, and MedShare Launch Program to Strengthen U.S. Healthcare Readiness for Natural Disasters
Business Wire1 week ago
Philips says no new French probe opened over sleep device recall
Reuters1 week ago
Philips Announces Plan for More Than USD 150 Million of New Investment in Manufacturing and R&D in the U.S. to Expand Production of AI-powered Health Technology Innovations
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Royal Philips stock?
Royal Philips (PHG) has a market cap of $27B as of September 18, 2025.
What is the P/E ratio for Royal Philips stock?
The price to earnings (P/E) ratio for Royal Philips (PHG) stock is 135.69 as of September 18, 2025.
Does Royal Philips stock pay dividends?
Yes, the Royal Philips (PHG) stock pays dividends to shareholders. As of September 18, 2025, the dividend rate is $0.8222 and the yield is 2.94%. Royal Philips has a payout ratio of 182.1% on a trailing twelve-month basis.
When is the next Royal Philips dividend payment date?
The next Royal Philips (PHG) dividend payment date is unconfirmed.
What is the beta indicator for Royal Philips?
Royal Philips (PHG) has a beta rating of 0.79. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.